VVUS

VIVUS Stock Price

0.4665
0.00 (0.0%)
0.4665
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
VIVUS Inc VVUS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.4665 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.4665
Bid Price Ask Price Spread News
0.4625 0.4626 0.00 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.4665 USD

VIVUS Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 8.34M 17.87M 17.64M $ 69.76M $ -29.03M -2.96 -0.29
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 13.80%

more financials information »

VIVUS News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VVUS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year1.884.500.43691.951,563,429-1.41-75.19%
3 Years4.359.880.43693.91580,602-3.88-89.28%
5 Years10.4018.500.43697.14613,265-9.93-95.51%

VIVUS Description

VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.


Your Recent History
NASDAQ
VVUS
VIVUS
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.